Karen Rittweger

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

Daniel G. Haller, Josep Tabernero, Jean A. Maroun et al. · Journal of Clinical Oncology · 2011 · 789 citations · Full text

Medicine, Oncology, Pharmacology +17

Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial

Hans‐Joachim Schmoll, Josep Tabernero, Jean A. Maroun et al. · Journal of Clinical Oncology · 2015 · 302 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results

J Cassidy, Stephen Clarke, Eduardo Díaz‐Rubio et al. · British Journal of Cancer · 2011 · 227 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase I Trial of 40-kd Branched Pegylated Interferon Alfa-2a for Patients With Advanced Renal Cell Carcinoma

Robert J. Motzer, Ashok Rakhit, Michelle S. Ginsberg et al. · Journal of Clinical Oncology · 2001 · 101 citations

Medicine, Oncology, Pharmacology +17

Treatment Rationale Study Design for the MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non–Small-Cell Lung Cancer

David R. Spigel, Martin J. Edelman, Tony Mok et al. · Clinical Lung Cancer · 2012 · 90 citations

Medicine, Oncology, Pharmacology +17